Syndax Pharmaceuticals Inc (NASDAQ: SNDX) on Monday, plunged -5.07% from the previous trading day, before settling in for the closing price of $21.3. Within the past 52 weeks, SNDX’s price has moved between $8.58 and $22.73.
During the last 5-year period, the sales drop of Healthcare Sector giant was -15.16%. The company achieved an average annual earnings per share of 16.89%. With a float of $84.30 million, this company’s outstanding shares have now reached $86.91 million.
Syndax Pharmaceuticals Inc (SNDX) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Syndax Pharmaceuticals Inc is 3.01%, while institutional ownership is 115.98%. The most recent insider transaction that took place on Sep 08 ’25, was worth 2,582,021. In this transaction Chief Executive Officer of this company sold 157,307 shares at a rate of $16.41, taking the stock ownership to the 298,661 shares. Before that another transaction happened on Sep 08 ’25, when Company’s Director proposed sale 157,307 for $17.04, making the entire transaction worth $2,680,511.
Syndax Pharmaceuticals Inc (SNDX) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -1.1 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.23) by -0.87. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.54 per share during the current fiscal year.
Syndax Pharmaceuticals Inc (NASDAQ: SNDX) Trading Performance Indicators
Syndax Pharmaceuticals Inc (SNDX) is currently performing well based on its current performance indicators. A quick ratio of 4.42 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.75.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.62, a number that is poised to hit -0.59 in the next quarter and is forecasted to reach -1.70 in one year’s time.
Technical Analysis of Syndax Pharmaceuticals Inc (SNDX)
Looking closely at Syndax Pharmaceuticals Inc (NASDAQ: SNDX), its last 5-days average volume was 1.13 million, which is a drop from its year-to-date volume of 1.38 million. As of the previous 9 days, the stock’s Stochastic %D was 32.15%.
During the past 100 days, Syndax Pharmaceuticals Inc’s (SNDX) raw stochastic average was set at 74.23%, which indicates a significant increase from 19.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.87 in the past 14 days, which was lower than the 0.94 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.18, while its 200-day Moving Average is $13.93. However, in the short run, Syndax Pharmaceuticals Inc’s stock first resistance to watch stands at $21.30. Second resistance stands at $22.39. The third major resistance level sits at $23.23. If the price goes on to break the first support level at $19.37, it is likely to go to the next support level at $18.53. Should the price break the second support level, the third support level stands at $17.44.
Syndax Pharmaceuticals Inc (NASDAQ: SNDX) Key Stats
Market capitalization of the company is 1.76 billion based on 86,915K outstanding shares. Right now, sales total 23,680 K and income totals -318,760 K. The company made 45,870 K in profit during its latest quarter, and -60,720 K in sales during its previous quarter.
